Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOte Ads Regulatory News (OTES)

Share Price Information for Ote Ads (OTES)

Share Price is delayed by 15 minutes
Get Live Data
11.03    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: $9.05b
OTES Live PriceLast checked at - London Stock Exchange

Intraday Ote Ads Share Chart

  • This share is an international stock.

EGM Voting Results

4 Nov 2022 14:40

RNS Number : 4214F
Hellenic Telecomms Organization S A
04 November 2022
 

Voting Results of the Extraordinary General Shareholders' Meeting of OTE S.A. of 01/11/2022

 

Athens, Greece - November 4, 2022 - Hellenic Telecommunications Organization S.A. (OTE S.A.), in accordance with the provisions of article 133, par. 2 of L. 4548/2018 and article 4.1.3.3 of the Athens Exchange Regulation, as in force, hereby releases the voting results of the Extraordinary General Shareholders' Meeting of November 1, 2022.

AGENDA ITEMS

 

ITEM No 1:

Approval of the Draft Demergers Agreement through Spin-Off of OTE S.A.'s business sector Facility and Space Management and its absorption by the OTE Group company, OTE ESTATE SOCIETE ANONYME, in accordance with articles 54 par.3, 57 par.2, 58-73 and 83-87 of L.4601/2019, L.4548/2018 & article 52 of L.4172/2013, with Accounting Statement dated 30/6/2022. - Appointment of representative of OTE S.A. to sign the Demergers Agreement notarial deed.

 

ITEM No 2:

Approval of cancellation of eight million, eight hundred and eighteen thousand seven hundred and thirty (8,818,730) own shares, purchased by the Company under the approved own share buy-back program in order to cancel them, with a corresponding reduction of its share capital by the amount of twenty four million, nine hundred and fifty seven thousand, five. Euros and ninety cents (€24,957,005.90), according to article 49 of L.4548/2018 and a subsequent amendment of article 5 (Share Capital) of the Company's Articles of Incorporation.

ITEM No 3:

Submission of a report of the independent members of the Board of Directors to the General Shareholders' Meeting, according to par. 5, article 9 of L.4706/2020.

ITEM No 4:

Miscellaneous announcements

 

 

 

 

 * Pursuant to article 50 of Law 4548/2018, the voting rights attaching to own shares are suspended and those shares are not taken into account for the calculation of quorum.

FOR FURTHER INFORMATION:

OTE GROUP INVESTOR RELATIONS

Tel. +30 210-6117364

E-mail: iroffice@ote.gr

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ROMBSBDBIXGDGDS
Date   Source Headline
11th Apr 20183:43 pmRNSOther Regulated Information
11th Apr 20188:36 amRNSAnnouncement - Purchase of Own Shares
5th Apr 20184:07 pmRNSAnnouncement-Purchase of Own Shares
4th Apr 20184:41 pmRNSAnnouncement-Purchase of Own Shares
3rd Apr 20184:04 pmRNSBuyback Intention
8th Mar 201812:45 pmRNSAnnouncement of Regulated Information
7th Mar 20182:13 pmRNSAnnouncement of Regulated Information
22nd Feb 20189:19 amRNSFinancial Results Q4 & FY 2017
21st Feb 20184:09 pmRNSFinancial Calendar 2018
20th Feb 20184:29 pmRNSEGM 15/02/2018 Voting Results
16th Feb 20183:53 pmRNSOwn Share Buy Back Programme
15th Feb 20183:27 pmRNSEGM 15/02/2018 Resolutions
26th Jan 20189:32 amRNSDate of Release 4Q17 Financial Results
19th Jan 20185:04 pmRNSEGM Meeting 15/02/2018
19th Jan 20187:42 amRNSAnnouncement of Regulated Information
6th Nov 20173:42 pmRNSAnnouncement of Regulated Information
17th Oct 20171:10 pmRNSAnnouncement of 3Q 2017 financial results day
11th Oct 20172:34 pmRNSAnnouncement of Regulated Information
28th Sep 20171:56 pmRNSAnnouncement of Regulated Information
25th Sep 20174:42 pmRNSAnnouncement of Regulated Information
22nd Aug 20172:59 pmRNSAnouncement of Regulated Information
3rd Aug 20179:24 amRNS2nd Quarter Results
18th Jul 20173:07 pmRNSAnnouncement of Regulated Information
12th Jul 201711:19 amRNSSECOND QUARTER 2017 FINANCIAL RESULTS UNDER IFRS
10th Jul 20174:36 pmRNSOTE Group concludes EUR300m financing package
6th Jul 201711:50 amRNSAnnouncement of Regulated Information
4th Jul 20171:06 pmRNSAnnouncement of Regulated Information
23rd Jun 201712:41 pmRNSVoting Results of the 65th AGM
21st Jun 20172:24 pmRNSDividend Distribution of Fiscal Year 2016
20th Jun 20173:52 pmRNS65th ORDINARY GENERAL MEETING OF SHAREHOLDERS
1st Jun 20178:21 amRNSPurchase of Own Shares
30th May 20171:22 pmRNSAGM Invitation
30th May 20177:00 amRNSAnnouncement of Regulated Information
24th May 20171:59 pmRNSAnnouncement of Regulated Information
23rd May 201711:25 amRNSAnnouncement of Regulated Information
18th May 201710:59 amRNSResults of the Extraordinary General Meeting
15th May 20175:17 pmRNSAnnouncement
11th May 20178:41 amRNS1st Quarter Results
9th May 20173:54 pmRNSAnnouncement of Regulated Information Revised
8th May 20175:40 pmRNSAnnouncement of Regulated Information
24th Apr 20172:54 pmRNS1Q 2017 FINANCIAL RESULTS TO BE RELEASED
20th Apr 20174:07 pmRNSINVITATION: EXTRAORDINARY GENERAL MEETING
13th Apr 20171:33 pmRNSRevised Financial Calendar 2017
13th Apr 20171:30 pmRNSReplacement of BoD Member
2nd Mar 20179:09 amRNS4th Quarter & Full Year 2016 Results
1st Mar 201711:49 amRNSFINANCIAL CALENDAR 2017
10th Feb 201711:19 amRNSAnnouncement for the 4Q & FY2016 Results
18th Jan 20173:47 pmRNSNew BoD Member
3rd Jan 20174:06 pmRNSresignation of a Bod member
23rd Dec 201611:21 amRNSEGM VOTING RESULTS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.